• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Jaguar Health, Inc. - Common Stock (NQ:JAGX)

    0.8049 -0.0601 (-6.95%)
    Streaming Delayed Price Updated: 2:16 PM EDT, Aug 28, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 132,784
    Open 0.8560
    Bid (Size) 0.7998 (200)
    Ask (Size) 0.8171 (200)
    Prev. Close 0.8650
    Today's Range 0.8000 - 0.8600
    52wk Range 0.7250 - 85.40
    Shares Outstanding 171,350,166
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Commercial Launch Initiated for Neonorm Dog, Jaguar Health's Non-Prescription Product for Support of Normal Stool Consistency and GI Fluid Balance in Dogs
    From Jaguar Health, Inc.
    Via ACCESS Newswire
    News headline image
    Jaguar Health Reports Q2 2026 Results: Full Earnings Call Transcript ↗
    Jaguar Health (NASDAQ:JAGX) released second-quarter financial results and hosted an earnings call on Wednesday. Read the complete transcript below. Benzinga APIs provide real-time access to earnings... 
    Via Benzinga
    Topics Earnings

    Performance

    YTD
    -97.7%
    -97.7%
    1 Month
    -16.5%
    -16.5%
    3 Month
    -75.5%
    -75.5%
    6 Month
    -97.3%
    -97.3%
    1 Year
    -98.7%
    -98.7%

    More News

    Read More
    News headline image
    Jaguar Health Reports Second Quarter 2026 Financials
    From Jaguar Health, Inc.
    Via ACCESS Newswire
    News headline image
    Jaguar Health to Hold Investor Webcast August 19 Regarding Q2 2026 Financials & Corporate Updates
    From Jaguar Health, Inc.
    Via ACCESS Newswire
    News headline image
    Jaguar Health Satisfies Conditions for Receipt of Non-Dilutive $2 Million Holdback Payment from Future Pak for Commercial License to Mytesi and Canalevia-CA1
    From Jaguar Health, Inc.
    Via ACCESS Newswire
    News headline image
    Jaguar Health Compliant with Nasdaq Bid Price Rule
    Via ACCESS Newswire
    Jaguar Health Inc (NASDAQ:JAGX) Swings to Profit on Licensing Deal, But Market Sells the News ↗
    Via Chartmill
    News headline image
    Jaguar Health Reports Positive Consumer and Veterinary Market Research Findings Supporting Commercial Opportunity for Neonorm Dog
    From Jaguar Health, Inc.
    Via ACCESS Newswire
    News headline image
    Additional Infant Patient to Receive Jaguar Health's Crofelemer for Compassionate Use for Treatment of Intestinal Failure (IF) Due to Microvillus Inclusion Disease (MVID)
    From Jaguar Health, Inc.
    Via ACCESS Newswire
    What's going on in today's session ↗
    Via Chartmill
    News headline image
    Presentation at ESPGHAN 2026 Describes Additional Groundbreaking Results of Evaluation of Jaguar Health's Crofelemer as Adjunctive Oral Therapy for the Treatment of Pediatric Intestinal Failure (IF)
    From Jaguar Health, Inc.
    Via ACCESS Newswire
    News headline image
    Life Sciences Virtual Investor Forum Presentations Now Available for On-Demand Viewing
    From Virtual Investor Conferences
    Via GlobeNewswire
    News headline image
    Jaguar Health Announces Conversion of Series O Convertible Preferred Stock Issued as Recent One-time Stock Dividend
    From Jaguar Health, Inc.
    Via ACCESS Newswire
    News headline image
    Jaguar Health Completes Submission of New Animal Drug Application for Full FDA Approval of Crofelemer for Treatment of Chemotherapy-Induced Diarrhea (CID) in Dogs
    From Jaguar Health, Inc.
    Via ACCESS Newswire
    News headline image
    Life Sciences Virtual Investor Forum Agenda Announced for June 24th & 25th
    From Virtual Investor Conferences
    Via GlobeNewswire
    News headline image
    Jaguar Health Announces Plan to Explore Strategic Alternatives Aligned with Targeted NDA Filing for Rare Disease Intestinal Failure Program
    From Jaguar Health, Inc.
    Via ACCESS Newswire
    News headline image
    Magdalena Biosciences, a Joint Venture Between Jaguar Health and Filament Health, Announces Positive Results of Preclinical Study of Coca for Weight Gain Prevention
    From Jaguar Health, Inc.
    Via ACCESS Newswire
    News headline image
    Jaguar Health Presenting June 24, 2026 at the Life Sciences Virtual Investor Forum to Provide Updates on Company's Crofelemer Development Program for Rare Intestinal Failure Diseases
    Via ACCESS Newswire
    News headline image
    Jaguar Health Reports Approval of All Proposals at 2026 Annual Meeting of Stockholders
    Via ACCESS Newswire
    News headline image
    Jaguar Health Research in Ethnobotanical Medicine Helps Advance Crofelemer Development for Genetically Defined Rare Congenital Gastrointestinal Disorders
    Via ACCESS Newswire
    News headline image
    Jaguar Health (JAGX) Q3 2025 Earnings Transcript ↗
    Via The Motley Fool
    Wondering what's happening in today's after-hours session? ↗
    Via Chartmill
    News headline image
    Jaguar Health Reports First Quarter 2026 Financials
    Via ACCESS Newswire
    News headline image
    Jaguar (JAGX) Q4 2025 Earnings Transcript ↗
    Via The Motley Fool
    News headline image
    Jaguar Health Announces Active Treatment Only Continuation of Pivotal Multicenter Clinical Trial in Pediatric Patients with Microvillus Inclusion Disease (MVID) to Support a New Drug Application (NDA) for Liquid Oral Crofelemer
    Via ACCESS Newswire

    Frequently Asked Questions

    Is Jaguar Health, Inc. - Common Stock publicly traded?
    Yes, Jaguar Health, Inc. - Common Stock is publicly traded.
    What exchange does Jaguar Health, Inc. - Common Stock trade on?
    Jaguar Health, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Jaguar Health, Inc. - Common Stock?
    The ticker symbol for Jaguar Health, Inc. - Common Stock is JAGX on the Nasdaq Stock Market
    What is the current price of Jaguar Health, Inc. - Common Stock?
    The current price of Jaguar Health, Inc. - Common Stock is 0.8049
    When was Jaguar Health, Inc. - Common Stock last traded?
    The last trade of Jaguar Health, Inc. - Common Stock was at 08/28/26 02:16 PM ET
    What is the market capitalization of Jaguar Health, Inc. - Common Stock?
    The market capitalization of Jaguar Health, Inc. - Common Stock is 137.92M
    How many shares of Jaguar Health, Inc. - Common Stock are outstanding?
    Jaguar Health, Inc. - Common Stock has 138M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.